Intelligent clinical triage and expert review backed by retinal AI.

Automatically prioritize vision-threatening pathology and resolve inconclusive cases with integrated specialist validation.

Ensure every encounter reaches a definitive conclusion.

Objective risk stratification identifies urgent pathology and flags ungradable images for expert human review.

Eye image labeled with diabetic retinopathy as vision-threatening, AMD as intermediate, and Glaucomatous signs as negative. Also a disclaimer that automated triage is limited to FDA-cleared DR detection results in the US by federal lawEye image labeled with diabetic retinopathy as vision-threatening, AMD as intermediate, and Glaucomatous signs as negative. Also a disclaimer that automated triage is limited to FDA-cleared DR detection results in the US by federal law.

risk

Managing a screening program at scale requires clinical closure for every patient. Our platform enables objective risk stratification to flag high-risk disease* and ungradable encounters, ensuring that both urgent and inconclusive cases receive the expert review necessary to preserve vision.

stratification

A unified platform for expert review and care coordination.

Centralized visibility. Professional resolution.

Resolve ungradables with human review

Fast-track cases requiring intervention

Ensure clinical closure for every patient

Automated result sync with your EHR

Minimize referral noise to save provider time

Centralized hub for program-wide visibility

Audit-ready records for quality compliance

Empower human graders across your network

Expand your diagnostic scope beyond DR.

Leverage expert human review with AI-triggered specialist validation for AMD and glaucomatous findings.

Distinguish between intermediate and late AMD, identifying high-risk patients who require a prioritized referral to a retinal specialist

Detect the presence of glaucomatous findings, enabling your network to identify potential suspected glaucoma early during a routine diabetic eye exam

All non-DR findings are based on expert human review, providing a comprehensive safety net that identifies critical pathology beyond DR

How clinics use EyeScreen

  • Stratify risk as AI categorizes exams based on DR findings and prioritize patient referrals
  • Flag inconclusive cases for expert review via EyeScreen, where human graders provide final overreads for clinical closure
  • Coordinate care by syncing validated results to the EHR to trigger prioritized specialist referrals

Explore Solutions.

Close-up of an elderly person's eye and surrounding wrinkles on their skin.Close-up of an older person's wrinkled skin and blue eye.

Transform every eye into a gateway to understanding.

Start FDA-cleared autonomous diabetic retinopathy screening in your clinic today.